期刊文献+

伏立康唑片的制备及其质量评价

Preparation and Evaluation of Voriconazole Tablets
原文传递
导出
摘要 目的制备并评价伏立康唑片。方法采用预胶化淀粉、一水乳糖、交联羧甲基纤维素钠、聚维酮、硬脂酸镁制备伏立康唑片,并对其进行薄膜包衣。采用正交设计法确定最佳处方。对其硬度、脆碎度和溶出度进行考察并与市售伏立康唑片比较。结果预胶化淀粉、一水乳糖、交联羧甲基纤维素钠、硬脂酸镁的用量分别为片重的40%,21%,3%和1%,采用5%聚维酮K90水溶液做黏合剂,片芯硬度为15 kg.cm 2,包衣厚度为4%左右时,伏立康唑片的溶出度接近原研产品。结论伏立康唑片的制备工艺简单,重现性好,药物的溶出行为达到预期目的。 OBJECTIVE To prepare and evaluate voriconazole tablets. METHODS The inactive ingredients of voriconazole tablets include pregelatinized starch, lactose monohydrate, croscarmellose sodium, povidone, magnesium stearate. The tablets were film coated. The formulation of the tablets was optimized by an orthogonal design. The hardness, friability and dissolution behavior of the voriconazole tablets was examined and compared with the commercial products. RESULTS The voriconazole tablets contained 40% pregelatinized starch, 21% lactose monohydrate, 3% croscarmellose sodium and 1% magnesium stearate with 5% PVP K90 solution as binder. The hardness was about 15 kg.cm-2 and the coating level was 4%. The dissolution behavior of the voriconazole tablets was similar to the original products. CONCLUSION The process of preparation is feasible. The in vitro dissolution property of the voriconazole tablets was satisfactory.
出处 《中国现代应用药学》 CAS CSCD 2013年第2期151-154,共4页 Chinese Journal of Modern Applied Pharmacy
基金 科技部"十一五"重大新药创制(2011ZX09401-306)
关键词 伏立康唑片 制备工艺 正交设计 溶出度 voriconazole tablets process of preparation orthogonal design dissolution
  • 相关文献

参考文献5

  • 1Herbrecht R,Denning DW,Patterson TF,et al.Voriconazole versus amphotericin B for primary therapy of invasive aspergillosis[].New England Journal of Homeopathy.2002
  • 2Walsh TJ,Pappas P,Winston DJ,et al.Voriconazole compared with liposomal amphotericin B for empirical antifungal therapy in patients with neutropenia and persistent fever[].The New England Journal of Medicine.2002
  • 3Enache-Angoulvant A,Girard A,Poirot JL,et al.In vitro activity of caspofungin and voriconazole against uncommon Candida spp[].International Journal of Antimicrobial Agents.2009
  • 4Quindos G,Sanchez-Vargas LO,Villar-Vidal M,et al.Activities of fluconazole and voriconazole against bloodstream isolates of Candida glabrata and Candida krusei:a 14-year study in a Spanish tertiary medical centre[].International Journal of Antimicrobial Agents.2008
  • 5PEN K K,WONG C F.Application of similarity factor indevelopment of controlled release diltiazem tablet[].DrugDev lnd Pharm.2000

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部